Human islet amyloid polypeptide transgenic mice as a model of non‐insulin‐dependent diabetes mellitus (NIDDM)

Authors:
  • JSJames Schrementi
    James Schrementi
  • MNMasahiro Nishi
    Masahiro Nishi
  • SOShinyo Ohagi
    Shinyo Ohagi
  • SCShu Jin Chan
    Shu Jin Chan
  • JHJudith A Heisserman
    Judith A Heisserman
  • GWGunilla T. Westermark
    Gunilla T. Westermark
  • ALArnold Leckström
    Arnold Leckström
  • PWPer Westermark
    Per Westermark
  • DSDonald F. Steiner
    Donald F. Steiner

Abstract
To model islet amyloidogenesis in NIDDM and explore the glucoregulatory role of islet amyloid polypeptide (IAPP), we have created transgenic micye containing a rat insulin‐I promoter‐human IAPP fusion gene. Expression of human IAPP was localized to the islets of Langerhans, anterior pituitary and brain in transgenic animals; blood IAPP levels were elevated 5‐fold while fasting glucose levels remained normal. Amyloid deposits have not been detected in transgenic islets suggesting that other co‐existing abnormalitites in NIDDM may be required for the formation of islet amyloid. These animals provide a unique model for exploring this hypothesis and other proposed functions of IAPP.

This publication has 30 references indexed in Scilit: